Table 1 Demographic details of the new-born subjects participated in the study.

From: Large scale validation of a new non-invasive and non-contact bilirubinometer in neonates with risk factors

Description

Number of Subjects

Neonates (N)

 

1968

TcB measurement (n)

 

1968

Mode of delivery

Spontaneous vaginal

590

Assistive vaginal

787

Elective C-section

394

Emergency C-section

197

Gestational Age (wk)

 < 35

435

35–376/7 (%)

558

38–396/7 (%)

482

40 (%)

82

Unknown

411

Birth Weight

Low birth weight (LBW)

708

Very low birth weight (VLBW)

258

Extremely low birth weight (ELBW)

45

Gender

Male

1,094

Female

873

Ambiguous (DSD)

01

Race

Asian

1968

Feeding

Breast (%)

1,377

Formula (%)

197

Both (%)

394

Unknown (%)

0

Post-natal age

 ≤ 24 h

73

24–47.9 h

206

48–71.9 h

586

 ≥ 72 h

1,103

Phototherapy

 

1,038

Blood transfusion

 

18

Disorders

ABO incompatibility

38

Rh-incompatibility

51

G6PD deficiency

34

Sepsis

46

Birth asphyxia

92

Others*

1707

  1. *Other disorders include maternal varicella, hypoglycaemia, jitteriness, sclerema, premature rupture of the membranes (PROM), apnoea of prematurity, intrauterine growth-retarded (IUGR), late-onset neonatal sepsis (LONS), gastric duplication cyst, pneumonia on mv, polycythaemia, hepatosplenomegaly, torch (+ Ve, HSV, CMV), congenital rubella, rubella (IgM +), neonatal convulsion, hyperthermia, laboured breathing, hypothyroid, osteogenesis imperfect, meningitis, congenital anomaly, Pierre Robin syndrome, chorioamnionitis, and mother hypothyroid.